| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMODERIV | Sep 1 | M | 2,497 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMODERIV | Sep 1 | M | 1,624 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMODERIV | Sep 1 | M | 1,750 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMODERIV | Sep 1 | M | 2,457 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMODERIV | Sep 1 | A | 26,750 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMODERIV | Sep 1 | A | 6,700 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMO | Sep 1 | F | 4,029 | $79.28 | $319K |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMO | Sep 1 | M | 2,457 | — | — |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMO | Sep 1 | M | 1,750 | — | — |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMO | Sep 1 | M | 1,624 | — | — |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMO | Sep 1 | M | 2,497 | — | — |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMODERIV | May 1 | MPLAN | 58,424 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMO | May 1 | SPLAN | 21,097 | $54.04 | $1.1M |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMO | May 1 | SPLAN | 37,327 | $53.52 | $2.0M |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMO | May 1 | MPLAN | 58,424 | $10.36 | $605K |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMODERIV | Apr 7 | M | 2,497 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMO | Apr 7 | F | 1,208 | $48.94 | $59K |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMO | Apr 7 | M | 2,497 | — | — |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMODERIV | Apr 1 | M | 2,457 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMODERIV | Apr 1 | M | 1,750 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMODERIV | Apr 1 | M | 1,624 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMODERIV | Apr 1 | A | 13,400 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMODERIV | Apr 1 | A | 6,700 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMODERIV | Apr 1 | A | 26,750 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMO | Apr 1 | F | 2,821 | $48.13 | $136K |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMO | Apr 1 | M | 5,831 | — | — |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMODERIV | Mar 2 | MPLAN | 40,000 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMO | Mar 2 | SPLAN | 5,714 | $45.92 | $262K |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMO | Mar 2 | SPLAN | 22,223 | $44.88 | $997K |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMO | Mar 2 | SPLAN | 12,063 | $44.20 | $533K |
| Kiniksa Pharmaceuticals International, plc | KNSA | John F. PaoliniCMO | Mar 2 | MPLAN | 40,000 | $10.36 | $414K |